REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY

T. E. Starzl, K. A. Porter, S. Iwatsuki, J. T. Rosenthal, B. W. Shaw, R. W. Atchison, M. A. Nalesnik, M. Ho, B. P. Griffith, T. R. Hakala, R. L. Hardesty, R. Jaffe, H. T. Bahnson

Research output: Contribution to journalArticle

958 Citations (Scopus)

Abstract

Post-transplant lymphomas or other lymphoproliferative lesions, which were usually associated with Epstein-Barr virus infections, developed in 8, 4, 3, and 2 recipients, respectively, of cadaveric kidney, liver, heart, and heart-lung homografts. Reduction or discontinuance of immunosuppression caused regression of the lesions, often without subsequent rejection of the grafts. Chemotherapy and irradiation were not valuable. The findings may influence policies about treating other kinds of post-transplantation neoplasms.

Original languageEnglish (US)
Pages (from-to)583-587
Number of pages5
JournalThe Lancet
Volume323
Issue number8377
DOIs
StatePublished - Mar 17 1984

Fingerprint

Neoplasm Transplantation
Cyclosporine
Lymphoma
Steroids
Epstein-Barr Virus Infections
Graft Rejection
Immunosuppression
Allografts
Transplants
Kidney
Drug Therapy
Lung
Liver
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Starzl, T. E., Porter, K. A., Iwatsuki, S., Rosenthal, J. T., Shaw, B. W., Atchison, R. W., ... Bahnson, H. T. (1984). REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY. The Lancet, 323(8377), 583-587. https://doi.org/10.1016/S0140-6736(84)90994-2

REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY. / Starzl, T. E.; Porter, K. A.; Iwatsuki, S.; Rosenthal, J. T.; Shaw, B. W.; Atchison, R. W.; Nalesnik, M. A.; Ho, M.; Griffith, B. P.; Hakala, T. R.; Hardesty, R. L.; Jaffe, R.; Bahnson, H. T.

In: The Lancet, Vol. 323, No. 8377, 17.03.1984, p. 583-587.

Research output: Contribution to journalArticle

Starzl, TE, Porter, KA, Iwatsuki, S, Rosenthal, JT, Shaw, BW, Atchison, RW, Nalesnik, MA, Ho, M, Griffith, BP, Hakala, TR, Hardesty, RL, Jaffe, R & Bahnson, HT 1984, 'REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY', The Lancet, vol. 323, no. 8377, pp. 583-587. https://doi.org/10.1016/S0140-6736(84)90994-2
Starzl TE, Porter KA, Iwatsuki S, Rosenthal JT, Shaw BW, Atchison RW et al. REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY. The Lancet. 1984 Mar 17;323(8377):583-587. https://doi.org/10.1016/S0140-6736(84)90994-2
Starzl, T. E. ; Porter, K. A. ; Iwatsuki, S. ; Rosenthal, J. T. ; Shaw, B. W. ; Atchison, R. W. ; Nalesnik, M. A. ; Ho, M. ; Griffith, B. P. ; Hakala, T. R. ; Hardesty, R. L. ; Jaffe, R. ; Bahnson, H. T. / REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY. In: The Lancet. 1984 ; Vol. 323, No. 8377. pp. 583-587.
@article{cc2226bda7da4a5a9d7de736766713ed,
title = "REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY",
abstract = "Post-transplant lymphomas or other lymphoproliferative lesions, which were usually associated with Epstein-Barr virus infections, developed in 8, 4, 3, and 2 recipients, respectively, of cadaveric kidney, liver, heart, and heart-lung homografts. Reduction or discontinuance of immunosuppression caused regression of the lesions, often without subsequent rejection of the grafts. Chemotherapy and irradiation were not valuable. The findings may influence policies about treating other kinds of post-transplantation neoplasms.",
author = "Starzl, {T. E.} and Porter, {K. A.} and S. Iwatsuki and Rosenthal, {J. T.} and Shaw, {B. W.} and Atchison, {R. W.} and Nalesnik, {M. A.} and M. Ho and Griffith, {B. P.} and Hakala, {T. R.} and Hardesty, {R. L.} and R. Jaffe and Bahnson, {H. T.}",
year = "1984",
month = "3",
day = "17",
doi = "10.1016/S0140-6736(84)90994-2",
language = "English (US)",
volume = "323",
pages = "583--587",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8377",

}

TY - JOUR

T1 - REVERSIBILITY OF LYMPHOMAS AND LYMPHOPROLIFERATIVE LESIONS DEVELOPING UNDER CYCLOSPORIN-STEROID THERAPY

AU - Starzl, T. E.

AU - Porter, K. A.

AU - Iwatsuki, S.

AU - Rosenthal, J. T.

AU - Shaw, B. W.

AU - Atchison, R. W.

AU - Nalesnik, M. A.

AU - Ho, M.

AU - Griffith, B. P.

AU - Hakala, T. R.

AU - Hardesty, R. L.

AU - Jaffe, R.

AU - Bahnson, H. T.

PY - 1984/3/17

Y1 - 1984/3/17

N2 - Post-transplant lymphomas or other lymphoproliferative lesions, which were usually associated with Epstein-Barr virus infections, developed in 8, 4, 3, and 2 recipients, respectively, of cadaveric kidney, liver, heart, and heart-lung homografts. Reduction or discontinuance of immunosuppression caused regression of the lesions, often without subsequent rejection of the grafts. Chemotherapy and irradiation were not valuable. The findings may influence policies about treating other kinds of post-transplantation neoplasms.

AB - Post-transplant lymphomas or other lymphoproliferative lesions, which were usually associated with Epstein-Barr virus infections, developed in 8, 4, 3, and 2 recipients, respectively, of cadaveric kidney, liver, heart, and heart-lung homografts. Reduction or discontinuance of immunosuppression caused regression of the lesions, often without subsequent rejection of the grafts. Chemotherapy and irradiation were not valuable. The findings may influence policies about treating other kinds of post-transplantation neoplasms.

UR - http://www.scopus.com/inward/record.url?scp=0021349053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021349053&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(84)90994-2

DO - 10.1016/S0140-6736(84)90994-2

M3 - Article

C2 - 6142304

AN - SCOPUS:0021349053

VL - 323

SP - 583

EP - 587

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8377

ER -